It is also possible that the use of growth hormones may differ between the subtypes, however, it is notable that in Australia, all children with genetically diagnosed PWS receive subsidized growth hormone treatment under the Pharmaceutical Benefit Scheme (PBS) until age 18, unless otherwise contraindicated [36], and without regard to genetic subtype. Here, GH1 is linked to Prader-Willi syndrome.